APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chinese Medicine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchChinese Medicine Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chinese Medicine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chinese Medicine Injection include ZBD Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Changbaishan Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Chase Sun Pharmaceutical, Green Valley Pharma, Livzon and Qingfeng Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Injection Segment by Company

ZBD Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Changbaishan Pharmaceutical

Wuzhou Pharmaceutical

Yusheng Pharmaceutical

Chase Sun Pharmaceutical

Green Valley Pharma

Livzon

Qingfeng Pharmaceutical Group

Gerun Pharmaceutical

Fusen Pharmaceutical

Shineway Pharmaceutical

Harbin Pharmaceutical Group

Buchang Pharmaceutical

Chinese Medicine Injection Segment by Type

Anti-tumor Drugs

Cerebrovascular Disease Medication

Detoxification

Cardiovascular Disease Medication

other

Chinese Medicine Injection Segment by Application

Adult

Children

Chinese Medicine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chinese Medicine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chinese Medicine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chinese Medicine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Injection Industry Trends Table 2. Chinese Medicine Injection Industry Drivers Table 3. Chinese Medicine Injection Industry Opportunities and Challenges Table 4. Chinese Medicine Injection Industry Restraints Table 5. Global Chinese Medicine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chinese Medicine Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Chinese Medicine Injection Sales Market Share by Manufacturers Table 9. Global Chinese Medicine Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Chinese Medicine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chinese Medicine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chinese Medicine Injection Manufacturers, Product Type & Application Table 13. Global Chinese Medicine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-tumor Drugs Table 17. Major Manufacturers of Cerebrovascular Disease Medication Table 18. Major Manufacturers of Detoxification Table 19. Major Manufacturers of Cardiovascular Disease Medication Table 20. Major Manufacturers of other Table 21. Global Chinese Medicine Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Chinese Medicine Injection Sales by Type (2021-2026) & (K Units) Table 23. Global Chinese Medicine Injection Sales by Type (2027-2032) & (K Units) Table 24. Global Chinese Medicine Injection Sales Market Share by Type (2021-2026) Table 25. Global Chinese Medicine Injection Sales Market Share by Type (2027-2032) Table 26. Global Chinese Medicine Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Chinese Medicine Injection Revenue by Type (2021-2026) & (K Units) Table 28. Global Chinese Medicine Injection Revenue by Type (2027-2032) & (K Units) Table 29. Global Chinese Medicine Injection Revenue Market Share by Type (2021-2026) Table 30. Global Chinese Medicine Injection Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Adult Table 32. Major Manufacturers of Children Table 33. Global Chinese Medicine Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Chinese Medicine Injection Sales by Application (2021-2026) & (K Units) Table 35. Global Chinese Medicine Injection Sales by Application (2027-2032) & (K Units) Table 36. Global Chinese Medicine Injection Sales Market Share by Application (2021-2026) Table 37. Global Chinese Medicine Injection Sales Market Share by Application (2027-2032) Table 38. Global Chinese Medicine Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Chinese Medicine Injection Revenue by Application (2021-2026) & (K Units) Table 40. Global Chinese Medicine Injection Revenue by Application (2027-2032) & (K Units) Table 41. Global Chinese Medicine Injection Revenue Market Share by Application (2021-2026) Table 42. Global Chinese Medicine Injection Revenue Market Share by Application (2027-2032) Table 43. Global Chinese Medicine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Chinese Medicine Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Chinese Medicine Injection Sales Market Share by Region (2021-2026) Table 46. Global Chinese Medicine Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Chinese Medicine Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Chinese Medicine Injection Sales by Country (2021-2026) & (K Units) Table 50. North America Chinese Medicine Injection Sales by Country (2027-2032) & (K Units) Table 51. Europe Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Chinese Medicine Injection Sales by Country (2021-2026) & (K Units) Table 53. Europe Chinese Medicine Injection Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Chinese Medicine Injection Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Chinese Medicine Injection Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Chinese Medicine Injection Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Chinese Medicine Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Chinese Medicine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Chinese Medicine Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Chinese Medicine Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Chinese Medicine Injection Revenue Market Share by Region (2021-2026) Table 64. Global Chinese Medicine Injection Revenue Market Share by Region (2027-2032) Table 65. ZBD Pharmaceutical Company Information Table 66. ZBD Pharmaceutical Business Overview Table 67. ZBD Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ZBD Pharmaceutical Chinese Medicine Injection Product Portfolio Table 69. ZBD Pharmaceutical Recent Development Table 70. Zhejiang Kanglaite Pharmaceutical Company Information Table 71. Zhejiang Kanglaite Pharmaceutical Business Overview Table 72. Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Product Portfolio Table 74. Zhejiang Kanglaite Pharmaceutical Recent Development Table 75. Changbaishan Pharmaceutical Company Information Table 76. Changbaishan Pharmaceutical Business Overview Table 77. Changbaishan Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Changbaishan Pharmaceutical Chinese Medicine Injection Product Portfolio Table 79. Changbaishan Pharmaceutical Recent Development Table 80. Wuzhou Pharmaceutical Company Information Table 81. Wuzhou Pharmaceutical Business Overview Table 82. Wuzhou Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Wuzhou Pharmaceutical Chinese Medicine Injection Product Portfolio Table 84. Wuzhou Pharmaceutical Recent Development Table 85. Yusheng Pharmaceutical Company Information Table 86. Yusheng Pharmaceutical Business Overview Table 87. Yusheng Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Yusheng Pharmaceutical Chinese Medicine Injection Product Portfolio Table 89. Yusheng Pharmaceutical Recent Development Table 90. Chase Sun Pharmaceutical Company Information Table 91. Chase Sun Pharmaceutical Business Overview Table 92. Chase Sun Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Chase Sun Pharmaceutical Chinese Medicine Injection Product Portfolio Table 94. Chase Sun Pharmaceutical Recent Development Table 95. Green Valley Pharma Company Information Table 96. Green Valley Pharma Business Overview Table 97. Green Valley Pharma Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Green Valley Pharma Chinese Medicine Injection Product Portfolio Table 99. Green Valley Pharma Recent Development Table 100. Livzon Company Information Table 101. Livzon Business Overview Table 102. Livzon Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Livzon Chinese Medicine Injection Product Portfolio Table 104. Livzon Recent Development Table 105. Qingfeng Pharmaceutical Group Company Information Table 106. Qingfeng Pharmaceutical Group Business Overview Table 107. Qingfeng Pharmaceutical Group Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Qingfeng Pharmaceutical Group Chinese Medicine Injection Product Portfolio Table 109. Qingfeng Pharmaceutical Group Recent Development Table 110. Gerun Pharmaceutical Company Information Table 111. Gerun Pharmaceutical Business Overview Table 112. Gerun Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Gerun Pharmaceutical Chinese Medicine Injection Product Portfolio Table 114. Gerun Pharmaceutical Recent Development Table 115. Fusen Pharmaceutical Company Information Table 116. Fusen Pharmaceutical Business Overview Table 117. Fusen Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Fusen Pharmaceutical Chinese Medicine Injection Product Portfolio Table 119. Fusen Pharmaceutical Recent Development Table 120. Shineway Pharmaceutical Company Information Table 121. Shineway Pharmaceutical Business Overview Table 122. Shineway Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Shineway Pharmaceutical Chinese Medicine Injection Product Portfolio Table 124. Shineway Pharmaceutical Recent Development Table 125. Harbin Pharmaceutical Group Company Information Table 126. Harbin Pharmaceutical Group Business Overview Table 127. Harbin Pharmaceutical Group Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Harbin Pharmaceutical Group Chinese Medicine Injection Product Portfolio Table 129. Harbin Pharmaceutical Group Recent Development Table 130. Buchang Pharmaceutical Company Information Table 131. Buchang Pharmaceutical Business Overview Table 132. Buchang Pharmaceutical Chinese Medicine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Buchang Pharmaceutical Chinese Medicine Injection Product Portfolio Table 134. Buchang Pharmaceutical Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Chinese Medicine Injection Distributors List Table 138. Chinese Medicine Injection Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Chinese Medicine Injection Product Image Figure 2. Global Chinese Medicine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Injection Sales (2021-2032) & (K Units) Figure 5. Global Chinese Medicine Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chinese Medicine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-tumor Drugs Image Figure 9. Cerebrovascular Disease Medication Image Figure 10. Detoxification Image Figure 11. Cardiovascular Disease Medication Image Figure 12. other Image Figure 13. Global Chinese Medicine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Chinese Medicine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chinese Medicine Injection Sales Market Share by Type (2021-2032) Figure 16. Global Chinese Medicine Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Chinese Medicine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Chinese Medicine Injection Revenue Market Share by Type (2021-2032) Figure 19. Adult Image Figure 20. Children Image Figure 21. Global Chinese Medicine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Chinese Medicine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chinese Medicine Injection Sales Market Share by Application (2021-2032) Figure 24. Global Chinese Medicine Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Chinese Medicine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Chinese Medicine Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Chinese Medicine Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Chinese Medicine Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Chinese Medicine Injection Sales Market Share by Country (2021-2032) Figure 41. China Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Chinese Medicine Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Chinese Medicine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Chinese Medicine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Chinese Medicine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Chinese Medicine Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Chinese Medicine Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Chinese Medicine Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Chinese Medicine Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Chinese Medicine Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Chinese Medicine Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-tumor Drugs
  • Cerebrovascular Disease Medication
  • Detoxification
  • Cardiovascular Disease Medication
  • other
Applications
  • Adult
  • Children
Companies covered
  • ZBD Pharmaceutical
  • Zhejiang Kanglaite Pharmaceutical
  • Changbaishan Pharmaceutical
  • Wuzhou Pharmaceutical
  • Yusheng Pharmaceutical
  • Chase Sun Pharmaceutical
  • Green Valley Pharma
  • Livzon
  • Qingfeng Pharmaceutical Group
  • Gerun Pharmaceutical
  • Fusen Pharmaceutical
  • Shineway Pharmaceutical
  • Harbin Pharmaceutical Group
  • Buchang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chinese Medicine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chinese Medicine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chinese Medicine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chinese Medicine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chinese Medicine Injection Market Dynamics
  1. 2.1 Chinese Medicine Injection Industry Trends
  2. 2.2 Chinese Medicine Injection Industry Drivers
  3. 2.3 Chinese Medicine Injection Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Injection Industry Restraints
3 Chinese Medicine Injection Market by Manufacturers
  1. 3.1 Global Chinese Medicine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chinese Medicine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chinese Medicine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chinese Medicine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chinese Medicine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chinese Medicine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Chinese Medicine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chinese Medicine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chinese Medicine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chinese Medicine Injection Tier 1, Tier 2, and Tier 3
4 Chinese Medicine Injection Market by Type
  1. 4.1 Chinese Medicine Injection Type Introduction
  2. 4.1.1 Anti-tumor Drugs
  3. 4.1.2 Cerebrovascular Disease Medication
  4. 4.1.3 Detoxification
  5. 4.1.4 Cardiovascular Disease Medication
  6. 4.1.5 other
  7. 4.2 Global Chinese Medicine Injection Sales by Type
  8. 4.2.1 Global Chinese Medicine Injection Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Chinese Medicine Injection Sales by Type (2021-2032)
  10. 4.2.3 Global Chinese Medicine Injection Sales Market Share by Type (2021-2032)
  11. 4.3 Global Chinese Medicine Injection Revenue by Type
  12. 4.3.1 Global Chinese Medicine Injection Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Chinese Medicine Injection Revenue by Type (2021-2032)
  14. 4.3.3 Global Chinese Medicine Injection Revenue Market Share by Type (2021-2032)
5 Chinese Medicine Injection Market by Application
  1. 5.1 Chinese Medicine Injection Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Chinese Medicine Injection Sales by Application
  5. 5.2.1 Global Chinese Medicine Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Medicine Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Chinese Medicine Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chinese Medicine Injection Revenue by Application
  9. 5.3.1 Global Chinese Medicine Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chinese Medicine Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Chinese Medicine Injection Revenue Market Share by Application (2021-2032)
6 Global Chinese Medicine Injection Sales by Region
  1. 6.1 Global Chinese Medicine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Chinese Medicine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chinese Medicine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chinese Medicine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chinese Medicine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chinese Medicine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chinese Medicine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chinese Medicine Injection Revenue by Region
  1. 7.1 Global Chinese Medicine Injection Revenue by Region
  2. 7.1.1 Global Chinese Medicine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chinese Medicine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Chinese Medicine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Chinese Medicine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chinese Medicine Injection Revenue (2021-2032)
  8. 7.2.2 North America Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chinese Medicine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chinese Medicine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chinese Medicine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chinese Medicine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ZBD Pharmaceutical
  2. 8.1.1 ZBD Pharmaceutical Company Information
  3. 8.1.2 ZBD Pharmaceutical Business Overview
  4. 8.1.3 ZBD Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ZBD Pharmaceutical Chinese Medicine Injection Product Portfolio
  6. 8.1.5 ZBD Pharmaceutical Recent Developments
  7. 8.2 Zhejiang Kanglaite Pharmaceutical
  8. 8.2.1 Zhejiang Kanglaite Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Kanglaite Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Product Portfolio
  12. 8.2.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
  13. 8.3 Changbaishan Pharmaceutical
  14. 8.3.1 Changbaishan Pharmaceutical Company Information
  15. 8.3.2 Changbaishan Pharmaceutical Business Overview
  16. 8.3.3 Changbaishan Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Changbaishan Pharmaceutical Chinese Medicine Injection Product Portfolio
  18. 8.3.5 Changbaishan Pharmaceutical Recent Developments
  19. 8.4 Wuzhou Pharmaceutical
  20. 8.4.1 Wuzhou Pharmaceutical Company Information
  21. 8.4.2 Wuzhou Pharmaceutical Business Overview
  22. 8.4.3 Wuzhou Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wuzhou Pharmaceutical Chinese Medicine Injection Product Portfolio
  24. 8.4.5 Wuzhou Pharmaceutical Recent Developments
  25. 8.5 Yusheng Pharmaceutical
  26. 8.5.1 Yusheng Pharmaceutical Company Information
  27. 8.5.2 Yusheng Pharmaceutical Business Overview
  28. 8.5.3 Yusheng Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yusheng Pharmaceutical Chinese Medicine Injection Product Portfolio
  30. 8.5.5 Yusheng Pharmaceutical Recent Developments
  31. 8.6 Chase Sun Pharmaceutical
  32. 8.6.1 Chase Sun Pharmaceutical Company Information
  33. 8.6.2 Chase Sun Pharmaceutical Business Overview
  34. 8.6.3 Chase Sun Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chase Sun Pharmaceutical Chinese Medicine Injection Product Portfolio
  36. 8.6.5 Chase Sun Pharmaceutical Recent Developments
  37. 8.7 Green Valley Pharma
  38. 8.7.1 Green Valley Pharma Company Information
  39. 8.7.2 Green Valley Pharma Business Overview
  40. 8.7.3 Green Valley Pharma Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Green Valley Pharma Chinese Medicine Injection Product Portfolio
  42. 8.7.5 Green Valley Pharma Recent Developments
  43. 8.8 Livzon
  44. 8.8.1 Livzon Company Information
  45. 8.8.2 Livzon Business Overview
  46. 8.8.3 Livzon Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Livzon Chinese Medicine Injection Product Portfolio
  48. 8.8.5 Livzon Recent Developments
  49. 8.9 Qingfeng Pharmaceutical Group
  50. 8.9.1 Qingfeng Pharmaceutical Group Company Information
  51. 8.9.2 Qingfeng Pharmaceutical Group Business Overview
  52. 8.9.3 Qingfeng Pharmaceutical Group Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qingfeng Pharmaceutical Group Chinese Medicine Injection Product Portfolio
  54. 8.9.5 Qingfeng Pharmaceutical Group Recent Developments
  55. 8.10 Gerun Pharmaceutical
  56. 8.10.1 Gerun Pharmaceutical Company Information
  57. 8.10.2 Gerun Pharmaceutical Business Overview
  58. 8.10.3 Gerun Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gerun Pharmaceutical Chinese Medicine Injection Product Portfolio
  60. 8.10.5 Gerun Pharmaceutical Recent Developments
  61. 8.11 Fusen Pharmaceutical
  62. 8.11.1 Fusen Pharmaceutical Company Information
  63. 8.11.2 Fusen Pharmaceutical Business Overview
  64. 8.11.3 Fusen Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fusen Pharmaceutical Chinese Medicine Injection Product Portfolio
  66. 8.11.5 Fusen Pharmaceutical Recent Developments
  67. 8.12 Shineway Pharmaceutical
  68. 8.12.1 Shineway Pharmaceutical Company Information
  69. 8.12.2 Shineway Pharmaceutical Business Overview
  70. 8.12.3 Shineway Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shineway Pharmaceutical Chinese Medicine Injection Product Portfolio
  72. 8.12.5 Shineway Pharmaceutical Recent Developments
  73. 8.13 Harbin Pharmaceutical Group
  74. 8.13.1 Harbin Pharmaceutical Group Company Information
  75. 8.13.2 Harbin Pharmaceutical Group Business Overview
  76. 8.13.3 Harbin Pharmaceutical Group Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Harbin Pharmaceutical Group Chinese Medicine Injection Product Portfolio
  78. 8.13.5 Harbin Pharmaceutical Group Recent Developments
  79. 8.14 Buchang Pharmaceutical
  80. 8.14.1 Buchang Pharmaceutical Company Information
  81. 8.14.2 Buchang Pharmaceutical Business Overview
  82. 8.14.3 Buchang Pharmaceutical Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Buchang Pharmaceutical Chinese Medicine Injection Product Portfolio
  84. 8.14.5 Buchang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Injection Value Chain Analysis
  2. 9.1.1 Chinese Medicine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Injection Production Mode & Process
  6. 9.2 Chinese Medicine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Injection Distributors
  9. 9.2.3 Chinese Medicine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst